No Data
No Data
Puma Stock Slumps, a Day After Adidas Rally. New Speedcat Range May Be to Blame.
Puma Launches Cost-Saving Program After 2024 Profit Falls Short of Expectations -- Update
Puma Misses Income Target Despite Sales Growth
Is Now The Time To Put Puma Biotechnology (NASDAQ:PBYI) On Your Watchlist?
SNY's Subcutaneous Sarclisa Proves Non-Inferior to IV Formulation (Revised)
Insider Sale: President and CEO of $PBYI (PBYI) Sells 33,841 Shares
EmotionOutofEquation : analysts fooled me last year with target $14 volatility luckily didn’t bet big size that was 2/3 year projection may be good luck anyway fundamentally buy signal here